Clinical Trial

Novo Nordisk A/S: Semaglutide 2.4 mg demonstrates superior improvement in both liver fibrosis and MASH resolution in the ESSENCE trial

Bagsværd, Denmark, 1 November 2024 – Novo Nordisk today announced the headline results from part 1 of the ongoing ESSENCE…

1 year ago

Sutro Biopharma Announces Initiation of the Registration-enabling REFRαME-P1 Trial with Luvelta for Pediatric Patients with CBF/GLIS AML

SOUTH SAN FRANCISCO, Calif., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a…

1 year ago

Verisante Technology, Inc. Announces Update to Proposed RTO with SunRegen Healthcare AG

VANCOUVER, BC / ACCESSWIRE / October 31, 2024 / Verisante Technology, Inc. (TSXV:VER.H) ("Verisante") is pleased to announce a transaction…

1 year ago

Hemostemix Announces the First Tranche Closing of $1.8M of Its Recently Announced Private Placement

Calgary, Alberta--(Newsfile Corp. - October 31, 2024) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company")…

1 year ago

Anju’s Feasibility Flex in TA Scan Wins Best of Show at SCOPE Summit Europe

FORT LAUDERDALE, Fla., Oct. 31, 2024 /PRNewswire/ -- Anju Software recently introduced Feasibility Flex, the newest feature in the flagship…

1 year ago

Kearney Releases Health Equity Report: Real-World Solutions in an Unfair System

Health Equity Can Be a Core Business Driver In the U.S., people in the least affluent zip codes can expect…

1 year ago

SHASQI TO PRESENT AT WORLD ADC AND SITC CONFERENCES

SAN FRANCISCO, Oct. 31, 2024 /PRNewswire/ -- Shasqi, Inc. ("Shasqi") a biotech company using in-vivo click chemistry to enable pre-targeting…

1 year ago

ifeel Selects TransPerfect Life Sciences for Digital Health Translation Initiatives

Localization & Voiceover Solutions Enable Global Expansion of Workplace Mental Health Resources NEW YORK, Oct. 31, 2024 /PRNewswire/ -- TransPerfect…

1 year ago

FluoSphera Expands Its Systemic Technology Platform to empower ADCs to meet their promise

GENEVA and BOSTON Oct. 31, 2024 /PRNewswire/ -- FluoSphera, the leader in systemic drug discovery, is excited to announce its strategic…

1 year ago

ADC Therapeutics to Host Third Quarter 2024 Financial Results Conference Call on November 7, 2024

LAUSANNE, Switzerland, Oct. 31, 2024 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the…

1 year ago